Boke Bioscience
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Boke Bioscience - overview
Established
2019
Location
Wuxi, Jiangsu, China
Primary Industry
Biotechnology
About
Based in Wuxi, China and established in 2019, Boke Bioscience is a biotechnology company that focuses on DNA technology and provides nano-pore sequencing platform. The company is dedicated to combining synthetic biology technologies with genomic approaches to provide nucleic acid products for academic research and commercial applications.
Current Investors
Jianxing Medical Fund
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.